−2.8075EUR
−517.48 MEUR
3.86 BEUR
151.68 M
About SUMITOMO DAINIPPON PHARMA CO.
Sector
CEO
Hiroshi Nomura
Headquarters
Osaka
Website
Employees (FY)
6.25 K
Founded
1897
ISIN
JP3495000006
FIGI
BBG000C1PVN2
Sumitomo Pharma Co., Ltd. engages in manufacture, sale, import, and export of pharmaceutical products. It operates through the Pharmaceutical Business and Other Business segments. The Pharmaceutical Business segment manufactures and sells generic and prescription drugs in Japan, North America, China, and other overseas countries. The Other Business segment division includes food ingredients, additives, chemical products, veterinary drugs, and diagnostic reagents. The company was founded on May 14, 1897 and is headquartered in Osaka, Japan.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
Depending on the exchange, the stock ticker may vary. For instance, on SWB exchange SUMITOMO DAINIPPON PHARMA CO. stocks are traded under the ticker DPM.
SUMITOMO DAINIPPON PHARMA CO. is going to release the next earnings report on May 14, 2024. Keep track of upcoming events with our Earnings Calendar.
One year price forecast for SUMITOMO DAINIPPON PHARMA CO. has a max estimate of 2.5570 EUR and a min estimate of 1.5220 EUR.
DPM earnings for the last quarter are −0.46 EUR per share, whereas the estimation was −0.27 EUR resulting in a −68.46% surprise. The estimated earnings for the next quarter are −0.37 EUR per share. See more details about SUMITOMO DAINIPPON PHARMA CO. earnings.
SUMITOMO DAINIPPON PHARMA CO. revenue for the last quarter amounts to 487.18 M EUR despite the estimated figure of 555.37 M EUR. In the next quarter revenue is expected to reach 589.62 M EUR.
Yes, you can track SUMITOMO DAINIPPON PHARMA CO. financials in yearly and quarterly reports right on TradingView.
DPM net income for the last quarter is −320.83 M EUR, while the quarter before that showed −182.80 M EUR of net income which accounts for −75.51% change. Track more SUMITOMO DAINIPPON PHARMA CO. financial stats to get the full picture.
Like other stocks, DPM shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade SUMITOMO DAINIPPON PHARMA CO. stock right from TradingView charts — choose your broker and connect to your account.
As of Apr 19, 2024, the company has 6.25 K employees. See our rating of the largest employees — is SUMITOMO DAINIPPON PHARMA CO. on this list?
We've gathered analysts' opinions on SUMITOMO DAINIPPON PHARMA CO. future price: according to them, DPM price has a max estimate of 2.56 EUR and a min estimate of 1.52 EUR. Read a more detailed SUMITOMO DAINIPPON PHARMA CO. forecast: see what analysts think of SUMITOMO DAINIPPON PHARMA CO. and suggest that you do with its stocks.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. SUMITOMO DAINIPPON PHARMA CO. EBITDA is −895.48 M EUR, and current EBITDA margin is 9.44%. See more stats in SUMITOMO DAINIPPON PHARMA CO. financial statements.